ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Infectious Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,931Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 35

$1.13M Total Retail Price of All Prescriptions

Rank: 10 out of 35

549 Patients Receiving at Least One Drug in Part D
59%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 549 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

32% of this provider’s 549 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

4% of this provider’s 9,359 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 62%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $459 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
HYDROCODONE-ACETAMINOPHEN 1,544 559 S3 1 6
LEVOTHYROXINE SODIUM 488 340 2 15
OMEPRAZOLE 420 246 3 13
NEXIUM 405 182 4 22
LISINOPRIL 370 245 5 10
SIMVASTATIN 355 254 6 20
FUROSEMIDE 330 217 7 23
ATORVASTATIN CALCIUM 313 203 8 19
AMLODIPINE BESYLATE 286 213 9 8
ZOLPIDEM TARTRATE 278 112 10 24
PROMETHAZINE HCL 246 118 R 11 34
METOPROLOL TARTRATE 239 189 12 30
PRAVASTATIN SODIUM 233 145 13 12
TRAMADOL HCL 226 109 14 36
CYMBALTA 225 77 15 29
METFORMIN HCL 220 115 16 25
OXYCODONE HCL-ACETAMINOPHEN 208 57 S2 17 38
POTASSIUM CHLORIDE 201 124 18 39
GABAPENTIN 198 89 19 21
CARISOPRODOL 196 18 R 20 40
HYDROCHLOROTHIAZIDE 183 146 21 18
CARVEDILOL 177 129 22 44
ALLOPURINOL 170 119 23 45
METOPROLOL SUCCINATE 159 141 24 46
CRESTOR 158 93 25 26
CITALOPRAM HBR 146 102 26 48
CLOPIDOGREL 146 88 26 48
WARFARIN SODIUM 142 94 28 51
GLYBURIDE-METFORMIN HCL 142 99 R 28 51
TRICOR 137 72 30 55
LISINOPRIL-HYDROCHLOROTHIAZIDE 136 60 31 31
ENDOCET 131 33 S2 32 58
ATENOLOL 129 79 33 59
ROPINIROLE HCL 127 83 34 61
DIOVAN HCT 114 61 35 64
FENTANYL 112 16 S2 36 65
TRAZODONE HCL 111 58 37 42
LOSARTAN-HYDROCHLOROTHIAZIDE 109 69 38 67
OXYCODONE HCL 108 12 S2 39 68
CYCLOBENZAPRINE HCL 108 22 R 39 68
PLAVIX 102 67 41 70
RANITIDINE HCL 98 36 42 71
ADVAIR DISKUS 96 55 43 72
GLIPIZIDE 95 71 44 73
PANTOPRAZOLE SODIUM 92 63 45 74
LIPITOR 91 64 46 75
FAMOTIDINE 91 50 46 35
JANUVIA 90 55 48 77
SPIRONOLACTONE 86 38 49 78
HYDROMORPHONE HCL 85 18 S2 50 79
MELOXICAM 83 60 51 80
FLUOXETINE HCL 82 42 52 81
AMLODIPINE BESYLATE-BENAZEPRIL 81 59 53 43
LEVOFLOXACIN 78 51 54 56
AMITRIPTYLINE HCL 77 28 R 55 53
SERTRALINE HCL 76 38 56 57
KLOR-CON M20 72 60 57 82
PROAIR HFA 72 16 57 37
METOCLOPRAMIDE HCL 71 47 59 85
VYTORIN 70 46 60 87
TIZANIDINE HCL 68 20 61 88
SINGULAIR 66 17 62 89
AZITHROMYCIN 66 43 62 41
MONTELUKAST SODIUM 66 19 62 89
LOSARTAN POTASSIUM 66 43 62 89
COMBIVENT 65 44 66 93
KLOR-CON M10 65 45 66 93
PREMARIN 63 29 R 68 95
DONEPEZIL HCL 63 62 68 95
PAROXETINE HCL 62 38 70 97
VENLAFAXINE HCL ER 62 0 70 97
OXYBUTYNIN CHLORIDE 62 59 70 97
TRIAMTERENE-HCTZ 61 42 73 101
BENICAR 59 26 74 102
FENOFIBRATE 58 40 75 103
VENTOLIN HFA 56 27 76 65
DEXILANT 54 27 77 104
KLOR-CON 10 54 25 77 104
ISOSORBIDE MONONITRATE ER 54 32 77 104
ZETIA 53 41 80 107
GLIPIZIDE ER 52 47 81 109
PRISTIQ ER 50 30 82 110
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 18, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.